GenixPharmaceucticals Corporation (GENX) — Cash Flow Reinvestment Rate

Latest as of April 2020: 9.91x

GenixPharmaceucticals Corporation (GENX) has a Cash Flow Reinvestment Rate of 9.91x as of April 2020, reinvesting CA$1.26 Million (capex CA$0.00 plus investments CA$-1.26 Million) from operating cash flow of CA$126.87K. See GenixPharmaceucticals Corporation net asset quality index to measure how much of total assets are equity-financed.

Reinvestment Rate

9.91x
(Capex + Investments) / Operating CF

Total Reinvested

CA$1.26 Million
Capex + Investments

Operating Cash Flow

CA$126.87K
CAD

Capital Expenditures

CA$0.00
CAD

GenixPharmaceucticals Corporation Cash Flow Reinvestment Rate (2018–2018)

Historical reinvestment intensity for GenixPharmaceucticals Corporation across 1 annual periods. Also explore GENX current and non-current assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for GenixPharmaceucticals Corporation (2018–2018)

Year-by-year capital reinvestment analysis for GenixPharmaceucticals Corporation. For live market cap and broader valuation context, see GENX market cap overview.

Year Reinvestment Rate Total Reinvested (CAD) Operating CF Capex YoY Change
2018 1.91x CA$65.34K CA$34.18K CA$0.00 —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow